Please sign in to follow a disease.
Scientists test synthetic nicotine and new Nicotine-Like chemicals in vapers
NCT ID NCT07348224
First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 6 times
Summary
This study will compare how synthetic nicotine and a nicotine analogue (6-methylnicotine) behave in the body versus traditional tobacco-derived nicotine. Twenty-four regular vapers will vape e-liquids containing these substances, and researchers will measure their levels in the blood and their effects. The goal is to understand if these newer products work the same way as standard nicotine.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- synthetic nicotine (S-nicotine, racemic nicotine) and nicotine analogue 6-methylnicotine
- What this could lead to
- If successful, this could clarify whether synthetic nicotine and nicotine analogues work like traditional nicotine, informing regulation and product safety.
- What could go wrong
- This is a small, early-phase study (24 people) that only measures short-term effects. Results may not apply to long-term use or broader populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 24 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Men or women, age 18 or older at screening who have used EC with nicotine during at least 10 of the past 30 days * Saliva cotinine concentration of \> 30 ng/mL at screening * Ability to communicate well with the investigator and to understand and comply with the requirements of the study * Women of child-bearing age engaging in sexual activities which can lead to pregnancy: willingness of using a reliable/hormonal contraception method during the study (hormonal, e.g. pill, intrauterine devices, or mechanical method, e.g. condom, diaphragm) * Signed informed consent form Exclusion Criteria: * Known hypersensitivity/allergy to a content of the e-liquids * Smoking of more than 5 cigarettes per day in the past 30 days * Pregnant or lactating women * Intention to become pregnant during the course of the study * BMI \< 18 or \> 30 kg/m2 at screening * History or clinical evidence of alcoholism or drug abuse within the 3-year period prior to screening * Loss of ≥ 250 mL of blood within 3 months prior to screening, including blood donation * Treatment with an investigational drug within 30 days prior to screening * Treatment with prescribed or over-the-counter medications with known influence on CYP2A6 function within 1 week prior to screening (with the exception of contraception) * History or clinical evidence of any disease (e.g. gastrointestinal tract-disease) and/or existence of any surgical or medical condition, which in the opinion of the investigator might interfere with the absorption, distribution, metabolism or excretion of the study drugs, or which might increase the risk of toxicity. * Legal incapacity or limited legal capacity at screening * Any circumstances or conditions, which, in the opinion of the investigator, may affect full participation in the study or compliance with the protocol
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Nicotine are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Inselspital
RECRUITINGBern, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Teens vs. vaping: can peer power break the habit?
- Will Acted-Out vaping stories persuade teens to stay away?
- Teens swayed by older-looking influencers in vaping ads, study finds
- Can stronger vape juice help you kick the habit?
- Phone calls to fight heart disease: new study tests coaching for young adults
- Teens see vape labels: will warnings work?